Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Milan, Italy; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland.
Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Milan, Italy.
Clin Genitourin Cancer. 2019 Jun;17(3):e541-e548. doi: 10.1016/j.clgc.2019.02.001. Epub 2019 Feb 13.
Patients with bladder cancer treated with radical cystectomy (RC) have heterogeneous results in term of cancer-specific (CSM) and other cause mortality (OCM). Our aim is to assess the impact of age on cause of death after RC.
We retrospectively analyzed the data of 1222 patients treated with RC and bilateral pelvic lymph node dissection owing to nonmetastatic bladder cancer between 1990 and 2013. Patients were stratified according to age (< 59 vs. 60-69 vs. 70-79 vs. ≥ 80 years), tumor T stage at RC (pT0-T2 vs. pT3-T4), and tumor N stage at RC (pN+ vs. pN0). Competing-risks survival analyses were used to estimate CSM and OCM rates.
With a median follow up of 6 years, 92 (7.5%) and 385 (31.5%) OCM and CSM were recorded. The 5-year CSM and OCM rates were 40% and 8.8%, respectively. After stratification according to disease stage and patient age, CSM emerged as the main cause of mortality in all patient subgroups. The 5-year OCM was 4.6%, 4.8%, 11%, and 32% for patients aged < 60 years versus 60 to 69 years versus 70 to 79 years versus ≥ 80 years, respectively. The 5-years CSM was 34%, 45%, 35%, and 56% for patients aged < 60 years versus 60 to 69 years versus 70 to 79 years versus ≥ 80 years, respectively. Similar findings were observed stratifying the population according to pathologic T and N stage.
CSM is the preponderant cause of death for all the patients, regardless of age or stage. In this regard, RC also seems to be a reasonable approach for octogenarians.
接受根治性膀胱切除术 (RC) 治疗的膀胱癌患者在癌症特异性 (CSM) 和其他原因死亡率 (OCM) 方面存在异质性结果。我们的目的是评估年龄对 RC 后死亡原因的影响。
我们回顾性分析了 1990 年至 2013 年间因非转移性膀胱癌接受 RC 和双侧盆腔淋巴结清扫术治疗的 1222 例患者的数据。根据年龄(<59 岁、60-69 岁、70-79 岁、≥80 岁)、RC 时的肿瘤 T 分期(pT0-T2 与 pT3-T4)和 RC 时的肿瘤 N 分期(pN+与 pN0)对患者进行分层。使用竞争风险生存分析来估计 CSM 和 OCM 率。
中位随访 6 年后,记录到 92 例(7.5%)和 385 例(31.5%)OCM 和 CSM。5 年 CSM 和 OCM 率分别为 40%和 8.8%。根据疾病阶段和患者年龄分层后,CSM 成为所有患者亚组死亡的主要原因。年龄<60 岁、60-69 岁、70-79 岁和≥80 岁的患者 5 年 OCM 分别为 4.6%、4.8%、11%和 32%。年龄<60 岁、60-69 岁、70-79 岁和≥80 岁的患者 5 年 CSM 分别为 34%、45%、35%和 56%。根据病理 T 和 N 分期对人群进行分层也观察到类似的结果。
CSM 是所有患者死亡的主要原因,无论年龄或分期如何。在这方面,RC 似乎也是 80 岁以上患者的合理治疗方法。